Defining ethical criteria to guide the expanded use of Noninvasive Prenatal Screening (NIPS): Lessons about severity from preimplantation genetic testing
- PMID: 39462080
- PMCID: PMC11840150
- DOI: 10.1038/s41431-024-01714-8
Defining ethical criteria to guide the expanded use of Noninvasive Prenatal Screening (NIPS): Lessons about severity from preimplantation genetic testing
Abstract
We hypothesized that ethical criteria that guide the use of preimplantation genetic testing (PGT) could be used to inform policies about expanded use of non-invasive prenatal screening (NIPS). We used a systematic review of reasons approach to assess ethical criteria used to justify using (or not using) PGT for genetic conditions. Out of 1135 identified documents, we retained and analyzed 216 relevant documents. Results show a clear distinction in acceptability of PGT for medical vs. non-medical conditions. Criteria to decide on use of PGT for medical conditions are largely based on their severity, but there is no clear definition of "severity". Instead, characteristics of the condition that relate to severity are used as sub-criteria to assess severity. We found that characteristics that are used as sub-criteria for assessing severity include monogenic etiology, high penetrance, absence of treatment, early age of onset, shortened lifespan, and reduced quality of life. Consensus about the use of PGT is highest for conditions that meet most of these criteria. There is no consensus around the acceptability of using PGT to detect non-medical conditions. We propose that the same severity criteria could be used by policymakers to assess the acceptability of using other genetic tests in screening and practice, including for the use of NIPS for additional conditions as indications broaden.
© 2024. The Author(s).
Conflict of interest statement
Competing interests: The authors declare no competing interests.
Figures

Similar articles
-
Day 5 versus day 3 embryo biopsy for preimplantation genetic testing for monogenic/single gene defects.Cochrane Database Syst Rev. 2022 Nov 24;11(11):CD013233. doi: 10.1002/14651858.CD013233.pub2. Cochrane Database Syst Rev. 2022. PMID: 36423200 Free PMC article.
-
Systemic Inflammatory Response Syndrome.2025 Jun 20. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. 2025 Jun 20. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. PMID: 31613449 Free Books & Documents.
-
Pressure-garment therapy for preventing hypertrophic scarring after burn injury.Cochrane Database Syst Rev. 2024 Jan 8;1(1):CD013530. doi: 10.1002/14651858.CD013530.pub2. Cochrane Database Syst Rev. 2024. PMID: 38189494 Free PMC article.
-
Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. doi: 10.3310/hta10340. Health Technol Assess. 2006. PMID: 16959170
-
Rapid, point-of-care antigen tests for diagnosis of SARS-CoV-2 infection.Cochrane Database Syst Rev. 2022 Jul 22;7(7):CD013705. doi: 10.1002/14651858.CD013705.pub3. Cochrane Database Syst Rev. 2022. PMID: 35866452 Free PMC article.
Cited by
-
Reevaluating 'seriousness' in genetic conditions: balancing clinical criteria and lived experiences.Eur J Hum Genet. 2025 Jun;33(6):699-700. doi: 10.1038/s41431-025-01829-6. Epub 2025 Mar 15. Eur J Hum Genet. 2025. PMID: 40089638 Free PMC article. No abstract available.
-
Editorial: severity in a genomic age.Eur J Hum Genet. 2025 Mar;33(2):144-146. doi: 10.1038/s41431-024-01766-w. Epub 2025 Feb 19. Eur J Hum Genet. 2025. PMID: 39972163 Free PMC article. No abstract available.
References
-
- Tian Y, Li M, Yang J, Chen H, Lu D. Preimplantation genetic testing in the current era, a review. Arch Gynecol Obstet. 2024;309:1787–99. 10.1007/s00404-024-07370-z. - PubMed
-
- Kater-Kuipers A, Bunnik EM, de Beaufort ID, Galjaard RJH. Limits to the scope of non-invasive prenatal testing (NIPT): an analysis of the international ethical framework for prenatal screening and an interview study with Dutch professionals. BMC Pregnancy Childbirth. 2018;18:409 10.1186/s12884-018-2050-4. - PMC - PubMed
-
- ACOG. Screening for fetal chromosomal abnormalities: ACOG practice bulletin summary, Number 226. Obstetr Gynecol. 2020;136:859–67. 10.1097/AOG.0000000000004107. - PubMed
-
- Shaw J, Scotchman E, Chandler N, Chitty LS. PREIMPLANTATION GENETIC TESTING: Non-invasive prenatal testing for aneuploidy, copy-number variants and single-gene disorders. Reproduction. 2020;160:A1–A11. 10.1530/REP-19-0591. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical